Research On The Optimization Of The Drug Supervision Mode At The Grass-roots Level From The Perspective Of Responsive Supervision

Drugs is a life necessity,and it’s safety directly influences the physical health and life security of the social masses,not to mention the economic development of the massive health industry,national life security and social stability.But the objective factors at the grassroots level that are at a disadvantage due to regulatory conditions,and rural areas are at a disadvantage.They are the weak links of drug regulation,and active areas of counterfeit drug manufacturing and sales,making the security of drugs unpromising.As far as the research on the existing drug supervision methods is concerned,there are many researches on the common problems existing in the process of the comprehensive implementation of drug supervision by the government and the optimization of the single drug supervision mode or supervision mechanism,while the research on the accuracy of the actual drug supervision mode at the grass-roots level is relatively less.Therefore,this article will combine the implementation of the 6 main drug supervision methods at the grassroots level and the theory of responsive supervision.In this paper,using the methods of literature analysis,case study and field research,taking Yongning District of Nanning City as an example,from the perspective of responsive supervision theory,the grassroots drug supervision mode at the grass-roots level in institutional reform is studied.According to the relevant research,the drug supervision mode at the grass-roots level mainly includes administrative licensing,supervision and inspection,administrative punishment,complaint reporting,adverse reaction monitoring,etc.,which lacks the response to the regulated subject,the molding of diversified regulatory subjects and the regulated subjects,the coordination between the regulatory bodies and the regulated subjects,and the problems of weak supervision network.The main reasons are that the reform of grassroots drug supervision is still in its infancy,the absence of pharmaceutical industry associations,the inadequate self-regulation of pharmaceutical manufacturers and the weak awareness of rights protection,etc.It is recommended to adopt measures such as understanding the actual situation of drug supervision and risk analysis to respond to the needs of regulatory bodies for standard construction;strengthening and promoting mechanism construction;enriching the functions of regulatory bodies,introducing multiple regulatory bodies,and optimizing primary drug regulatory methods to further improve drug regulatory performance.